
Mesoblast’s AGM Results: All Resolutions Passed on November 25, 2025

I'm PortAI, I can summarize articles.
Mesoblast Limited announced that all resolutions were passed at its Annual General Meeting on November 25, 2025. The resolutions included the adoption of the remuneration report, election and re-election of directors, and approval of options and convertible notes. This reflects strong shareholder support and is expected to positively impact the company's strategic direction. Despite financial challenges, Mesoblast shows potential for future growth. The current analyst rating for MESO stock is Hold with a $14.50 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

